Recombinant T-complex protein 1 subunit alpha (cct-1), partial

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context

Recombinant T-complex protein 1 subunit alpha (CCT-1), partial refers to a genetically engineered fragment of the TCP1 protein, which is part of the 16-subunit TRiC/CCT complex. This ATP-dependent chaperonin facilitates the folding of cytoskeletal proteins like actin and tubulin, along with other aggregation-prone polypeptides . The "partial" designation indicates that the recombinant protein lacks certain regions of the full-length native protein, often optimized for experimental utility .

Key Features

  • Molecular Weight: ~58 kDa (recombinant fragment) .

  • Domain Architecture: The full-length TCP1 contains equatorial, intermediate, and apical domains critical for ATP hydrolysis and substrate binding .

  • Post-Translational Modifications: Native TCP1 undergoes N-terminal methionine excision and acetylation, but recombinant forms may lack these modifications depending on the expression system .

Functional Roles

  • Substrate Folding: Assists in folding actin, tubulin, and other obligate substrates by enclosing them in the TRiC chamber during ATP-driven conformational changes .

  • Cellular Homeostasis: Prevents aggregation of misfolded proteins linked to neurodegenerative diseases .

  • Complex Assembly: Interacts with other CCT subunits (CCT1–CCT8) in a conserved hetero-oligomeric arrangement .

Functional Studies

  • Actin Folding: Recombinant TRiC containing CCT-1 restores folded actin production in vitro, demonstrating kinetics comparable to native TRiC .

  • Disease Relevance: TRiC/CCT mitigates aggregation of amyloidogenic proteins, such as huntingtin, highlighting therapeutic potential .

Technical Advancements

  • Baculovirus Co-Expression: Enables simultaneous production of all eight CCT subunits, overcoming challenges in recombinant TRiC assembly .

  • Mass Spectrometry: Detects post-translational modifications (e.g., N-terminal acetylation) and validates subunit stoichiometry .

Comparative Analysis of CCT-1 Constructs

FeatureFull-Length TCP1Recombinant Partial CCT-1
Size~60 kDa~58 kDa (truncated)
ModificationsN-terminal acetylationOften unmodified
Functional AssaysNative folding kineticsRetains ~80% activity in vitro
Research UtilityLimited by solubilityEnhanced solubility for structural studies

Challenges and Future Directions

  • Partial Protein Limitations: Truncated forms may lack regions critical for inter-subunit interactions or substrate recognition .

  • Therapeutic Development: Engineering full-length, post-translationally modified CCT-1 remains a hurdle for drug discovery .

Product Specs

Form
Lyophilized powder. Note: We will prioritize shipping the format we have in stock. If you have specific format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times may vary based on purchasing method and location. Please contact your local distributor for specific delivery information. Note: All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional fees will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize developing it.
Synonyms
cct-1; tcp-1; T05C12.7; T-complex protein 1 subunit alpha; TCP-1-alpha; CCT-alpha
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Caenorhabditis elegans
Target Names
cct-1
Uniprot No.

Target Background

Function
Molecular chaperone. This protein facilitates protein folding through ATP hydrolysis and is known to play a role in vitro in the folding of actin and tubulin.
Database Links
Protein Families
TCP-1 chaperonin family
Subcellular Location
Cytoplasm.

Q&A

Basic Research Questions

  • What is T-complex protein 1 subunit alpha (CCT-1) and how does it function within the chaperonin complex?

    T-complex protein 1 subunit alpha (CCT-1) is one of eight paralogous subunits that form the eukaryotic group II chaperonin complex known as TRiC (TCP1 ring complex), TCP-1 (T-complex polypeptide-1), or CCT (chaperonin-containing TCP1). The complex forms a double-toroidal structure with two identical rings, each composed of eight subunits (α, β, γ, δ, ε, ζ, η, and θ) .

    CCT-1, as the alpha subunit, contributes to the ATP-dependent folding mechanism that assists in the proper folding of approximately 10% of newly synthesized cytosolic proteins, including crucial proteins like actin and tubulin . While individual subunits have been shown to form homo-oligomeric complexes with independent activities in some cases, the coordinated function of all subunits in the hetero-oligomeric complex is typically required for optimal folding of substrate proteins.

  • How do researchers distinguish between CCT-1's function and other TCP1 subunits in experimental settings?

    Distinguishing the specific functions of CCT-1 from other TCP1 subunits involves several methodological approaches:

    • Subunit-specific antibodies: Using antibodies that specifically recognize CCT-1 allows for immunoprecipitation studies to identify its unique interacting partners.

    • Recombinant expression: By expressing CCT-1 alone, researchers can study whether it forms functional homo-oligomeric complexes, similar to what has been shown with the gamma subunit in Leishmania donovani .

    • Substrate specificity analysis: Comparing the substrate profiles between different subunits helps identify CCT-1-specific clients. For example, studies with TCP1γ identified 719 interacting proteins, including various metabolic enzymes .

    • Mutagenesis studies: Creating point mutations in specific domains of CCT-1 can reveal its unique contributions to substrate recognition or ATP hydrolysis within the complex.

  • What is the current understanding of CCT-1's substrate recognition mechanism?

    The substrate recognition mechanism of CCT-1 involves:

    • Hydrophobic interactions: CCT-1 recognizes exposed hydrophobic regions of unfolded or partially folded proteins.

    • Specific binding motifs: Research suggests that CCT-1 may recognize specific amino acid sequences or structural motifs in substrate proteins.

    • Cooperative binding: While CCT-1 may have its own substrate preferences, it works cooperatively with other subunits in the TCP1 complex to bind and fold substrate proteins.

    • Co-chaperone interactions: CCT-1 may interact with co-chaperones that help deliver specific substrates to the complex.

    Comparative studies examining the interactomes of different TCP1 subunits have shown both overlapping and distinct substrate profiles, suggesting that CCT-1 has both shared and unique roles within the complex .

Experimental Design and Methodology

  • What are the optimal expression systems for producing functional recombinant CCT-1?

    Based on research with other TCP1 subunits, several expression systems have proven effective for producing functional recombinant CCT-1:

    • Bacterial expression systems: E. coli BL21(DE3) with pET vectors under T7 promoter control can yield high quantities of protein, though refolding may be required.

    • Yeast expression systems: S. cerevisiae or P. pastoris can provide eukaryotic post-translational modifications and chaperone assistance.

    • Insect cell expression: Baculovirus expression systems in Sf9 or Hi5 cells often yield properly folded protein with high activity.

    • Mammalian cell expression: HEK293 or CHO cells can be used when mammalian-specific modifications are critical.

    Expression parameters should be optimized to prevent aggregation, including lower induction temperatures (16-25°C), reduced inducer concentrations, and co-expression with molecular chaperones to facilitate proper folding .

  • What purification strategies maintain the structural integrity and activity of recombinant CCT-1?

    Effective purification strategies include:

    • Affinity chromatography: His-tag or GST-tag purification under gentle conditions (neutral pH, physiological salt concentration).

    • Size exclusion chromatography: Critical for separating monomeric, homo-oligomeric, and potentially aggregated forms of CCT-1.

    • Ion exchange chromatography: For removing contaminants while maintaining native conformation.

    • ATP-agarose chromatography: Leverages CCT-1's nucleotide-binding properties for specific purification.

    Throughout purification, adding ATP (1-5 mM) and magnesium (5-10 mM) helps stabilize the protein's active conformation. Glycerol (10-15%) and reducing agents like DTT (1-5 mM) further protect against denaturation and oxidation .

  • How can researchers assess the folding activity of recombinant CCT-1?

    Assessing the folding activity of recombinant CCT-1 can be accomplished through multiple complementary approaches:

    • ATP hydrolysis assays: Measuring ATPase activity using colorimetric phosphate detection methods or coupled enzyme assays.

    • Substrate folding assays: Monitoring the folding of model substrates like denatured luciferase or green fluorescent protein.

    • Thermal shift assays: Evaluating protein stability in the presence/absence of ATP and substrate proteins.

    • Light scattering: Detecting the prevention of substrate aggregation.

    • Circular dichroism spectroscopy: Assessing the secondary structure of substrate proteins before and after interaction with CCT-1.

    • Limited proteolysis: Comparing proteolytic patterns of CCT-1 in different nucleotide-bound states to assess conformational changes .

Advanced Research Questions

  • How does CCT-1 interact with the other seven TCP1 subunits to form the functional chaperonin complex?

    The interaction between CCT-1 and other TCP1 subunits involves several key mechanisms:

    • Ordered assembly: Research suggests that subunits assemble in a specific order, with CCT-1 potentially playing a nucleating role in complex formation.

    • Inter-subunit contacts: CCT-1 forms specific contacts with neighboring subunits (typically CCT-8/θ and CCT-4/δ in the canonical arrangement) through conserved interface regions.

    • Allosteric communication: Conformational changes in CCT-1 propagate through the ring structure, coordinating ATP hydrolysis and substrate folding.

    • Hierarchical organization: Studies have shown that TCP1 subunits may have different abundances in the cell, suggesting a hierarchy in complex assembly where certain subunits like CCT-1 may be rate-limiting .

    Based on studies of TCP1γ in Leishmania, which can form functional homo-oligomeric complexes, CCT-1 may also have independent functions outside the complete TCP1 complex, potentially forming homo-oligomers or subcomplexes with other subunits .

  • What is the interactome of CCT-1 and how does it differ from other TCP1 subunits?

    Based on comparative studies with TCP1γ in Leishmania, we can infer that CCT-1 likely has both overlapping and unique interacting partners. The interactome analysis would reveal:

    Functional CategoryRepresentative CCT-1 Interacting PartnersInteraction Specificity
    Cytoskeletal proteinsActin, tubulin, intermediate filamentsShared with most TCP1 subunits
    Metabolic enzymesEnolase, phosphoglycerate kinase, isocitrate dehydrogenasePartially subunit-specific
    Signaling proteinsProtein kinases, phosphatasesOften subunit-specific
    Transcription factorsVarious nuclear factorsHighly subunit-specific
    Other chaperonesHsp70, Hsp90, co-chaperonesShared with most TCP1 subunits

    Studies of TCP1γ identified 719 interacting proteins spanning various cellular pathways, including metabolic processes, protein folding, sorting, and degradation . CCT-1 would likely show some overlap but also distinct interactions reflecting its unique substrate specificities and functions within the complex.

  • How do post-translational modifications regulate CCT-1 function?

    Post-translational modifications (PTMs) of CCT-1 play crucial roles in regulating its function:

    • Phosphorylation: May regulate ATP binding/hydrolysis, interactions with substrates, or assembly into the TRiC complex.

    • Acetylation: Could affect substrate recognition domains and interactions with other cellular factors.

    • Ubiquitination: May target CCT-1 for degradation or regulate non-canonical functions.

    • Sumoylation: Potentially involved in localizing CCT-1 to specific cellular compartments or regulating interactions with certain substrates.

    Studies of other TCP1 subunits have revealed that PTMs can significantly alter their function, localization, and interactions. For example, phosphorylation events have been shown to regulate chaperonin activity in response to cellular stress or during cell cycle progression .

Troubleshooting and Data Analysis

  • What strategies help overcome solubility and folding challenges when expressing recombinant CCT-1?

    When encountering solubility issues with recombinant CCT-1, researchers can employ these strategies:

    • Fusion tags: Solubility-enhancing tags like MBP (maltose-binding protein), SUMO, or Thioredoxin can dramatically improve soluble expression.

    • Co-expression with other TCP1 subunits: Expression with partner subunits can enhance proper folding and solubility of CCT-1.

    • Chaperone co-expression: Co-expressing with bacterial chaperones (GroEL/ES, DnaK/J/GrpE) or relevant eukaryotic chaperones.

    • Refolding protocols: If inclusion bodies form, specialized refolding protocols using gradual dialysis with ATP and magnesium have shown success with other TCP1 subunits .

    • Expression temperature optimization: Reducing temperature to 16-20°C significantly improves folding efficiency.

    • Induction optimization: Using lower concentrations of inducer and extending expression time can promote proper folding.

  • How can researchers distinguish between CCT-1's role in homo-oligomeric versus hetero-oligomeric complexes?

    Distinguishing between CCT-1's functions in different oligomeric states requires several complementary approaches:

    • Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS): Accurately determines the molecular weight of different oligomeric forms.

    • Native gel electrophoresis: Separates different oligomeric states while preserving their native structure.

    • Analytical ultracentrifugation: Provides detailed information about the size, shape, and heterogeneity of CCT-1 complexes.

    • Cryo-electron microscopy: Visualizes the structural organization of different complexes.

    • Subunit-specific antibody depletion: Selectively removing specific TCP1 subunits can reveal which functions remain with CCT-1 alone.

    • Activity assays with purified oligomeric states: Testing the folding activity of isolated homo-oligomeric versus hetero-oligomeric complexes with various substrates.

    Studies of TCP1γ in Leishmania have shown it can form functional homo-oligomeric complexes that exhibit ATP-dependent refolding activity, suggesting CCT-1 might have similar capabilities .

  • What are the known functional differences between recombinant and native CCT-1?

    Recombinant CCT-1 may differ from its native counterpart in several important ways:

    CharacteristicNative CCT-1Recombinant CCT-1Methodological Considerations
    Post-translational modificationsContains cell-specific PTMsMay lack essential PTMsUse eukaryotic expression systems
    Complex formationIntegrated into TRiC complexOften exists as monomer or homo-oligomerCo-express with other subunits
    ATPase activityCoordinated with other subunitsUsually higher but unregulatedMeasure activity under various conditions
    Substrate specificityBroader due to complex formationMay recognize only a subset of native substratesUse diverse substrate panels
    StabilityEnhanced by complex integrationGenerally less stableAdd stabilizing agents (ATP, glycerol)

    Researchers can bridge these differences by:

    • Expressing CCT-1 in eukaryotic systems to preserve PTMs

    • Co-expressing with other TCP1 subunits

    • Adding cofactors like ATP and magnesium

    • Using physiological buffers and temperature conditions

    • Considering the assembly state when interpreting functional data

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.